Technology Transfer & Scale-Up Oversight
Guaranteeing a seamless transition from bench to commercial manufacturing with rigorous, ICH-compliant oversight and uncompromising clinical precision.
The Scale-Up Disconnect
A flawless bench-scale formulation means nothing if it cannot be industrialised. The transition from a controlled R&D laboratory to a GMP manufacturing suite is the most perilous phase of drug development. When sponsors attempt to hand off a static formulation document to a bulk manufacturer without continuous, highly technical oversight, they frequently face disastrous batch failures, unresolvable equipment mismatches, and severe regulatory delays.
Uncompromising Technical Stewardship
We do not simply hand over a formula; we govern its execution. As your technical co-architects, Dhee Lifesciences acts as your dedicated scientific proxy on the manufacturing floor. We meticulously architect the Chemistry, Manufacturing, and Controls (CMC) strategy, establishing rigorous Critical Quality Attributes (CQAs) and Critical Process Parameters (CPPs). By driving the technology transfer to your chosen manufacturing partners, we definitively safeguard the asset’s integrity through to commercial scale
Accelerated by the SynapTx™ AI Ecosystem
Scale-up involves complex thermodynamics, fluid dynamics, and mechanical stress that cannot be solved by guesswork. SynapTx™ computationally anticipates the impact of industrial-scale forces on your specialised formulation. By parsing decades of historical technology transfer data and compliance registries, our local AI platform identifies latent scale-up vulnerabilities before the first commercial batch is even scheduled, ensuring absolute regulatory certainty.